COSCIENS Biopharma Raises $4.4 Million Via Second Tranche of Convertible Debenture Offering

07:15 AM EDT, 09/17/2026 (MT Newswires) -- COSCIENS Biopharma (CSCI.TO) closed the second tranche of a non-brokered private placement of the 15% unsecured convertible debentures, raising $4.4 million, it said in a statement late Wednesday. Together with the first closing, the company raised $10.7 million. COSCIENS anticipates closing one or more additional tranches in the coming weeks, it said. The company's shares last traded Sept. 15, closing at CA$7.45 on the Toronto Stock Exchange.